Lipogems received FDA 510(k) clearance to market a Microfragmented Adipose Tissue Transplant system for use in orthopaedic and arthroscopic procedures.Â
By the end of 2Q18, Episurf Medical will file for its Investigational Device Exemption with FDA to initiate a U.S. study of the Episealer® knee implant.
Globus Medical marked a milestone with successful implantation of >3,000 screws with ExcelsiusGPS® robotic guidance and navigation since late-2017 launch.